Skip to main content
Top
Published in: Endocrine Pathology 2/2002

01-06-2002 | Clinical Research

Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques

Authors: Dr. Nobue Kumaki, MD, Hiroshi Kajiwara, MD, Kaori Kameyama, MD, Ronald A. DeLellis, MD, Sylvia L. Asa, MD, R. Yoshiyuki Osamura, MD, Hiroshi Takami, MD

Published in: Endocrine Pathology | Issue 2/2002

Login to get access
Metadata
Title
Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques
Authors
Dr. Nobue Kumaki, MD
Hiroshi Kajiwara, MD
Kaori Kameyama, MD
Ronald A. DeLellis, MD
Sylvia L. Asa, MD
R. Yoshiyuki Osamura, MD
Hiroshi Takami, MD
Publication date
01-06-2002
Publisher
Humana Press
Published in
Endocrine Pathology / Issue 2/2002
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1385/EP:13:2:149

Other articles of this Issue 2/2002

Endocrine Pathology 2/2002 Go to the issue

Announcement

Announcement

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine